EXCLUSIVE: FDA Commissioner Marty Makary Says He’s Taking Politics Out Of Science
Softball Interview
How They Deceive You
Propaganda
Notable spin via favorable framing of unverified claims from a Trump appointee, cherry-picking successes, and omitting internal FDA turmoil.
Main Device
Softball Interview
Presents exclusive quotes from FDA Commissioner Makary without pushback, verification, or counter-quotes, amplifying his self-praise and policy boasts.
Archetype
Pro-Trump regulatory reformer booster
Daily Wire piece hypes a conservative FDA head's anti-Biden, anti-Big Pharma narrative to appeal to right-wing audiences.
This article informs via direct access to Makary but deceives by unchallenged unverified claims, selective successes, and omissions of FDA criticisms.
Writer's Worldview
“Pro-Trump regulatory reformer booster”
7 findings · 2 omissions · 5 sources compared
What is your news hiding from you?
Same analysis. Any article. Completely free.
Narrative Analysis
Verdict: This Daily Wire exclusive provides valuable direct access to FDA Commissioner Marty Makary's claims on restoring "gold standard science," accurately quoting him and noting some verified initiatives like a school lunch pesticide pilot, but reports several unverified assertions without caveat and omits documented reports of internal FDA dysfunction.
Key Strengths and Techniques
- Exclusive access delivers fresh quotes: The piece centers Makary's interview, offering specifics like commitments to a mifepristone safety study and actions against artificial food dyes—rare primary-source insight into a Trump appointee's priorities.
- > “We have brought back gold standard science and taken politics out of the process... We are going up against Big Food, Big Pharma."
- Acknowledges bipartisan criticism: Briefly notes Democratic pushback on vaccines and pro-life calls for resignation over abortion pill inaction, adding balance without deep exploration.
- Verified elements build credibility:
- School lunch pilot achieved 70-80% pesticide reduction (confirmed in FDA reports).
- General FDA push on artificial dyes aligns with agency announcements.
Notable Issues: Unverified Claims
Several Makary quotes lack external confirmation, presented as fact:
- China's phase-one trials: "China was doing four times the number of phase one trials as the United States" in the year before Makary's tenure—no public data matches this exact ratio.
- Mifepristone study: Claim of an underway "granular study"—FDA site and searches show no such announcement.
- Biden vaccine override: "The Biden administration overruled scientists who recommended against approving the Covid vaccine for healthy children"—no records confirm scientists' opposition or overruling.
- Dye removal scope: "Remove all nine artificial dyes"—FDA mentions dye phase-out but not "nine" specifically.
These rely on single-source attribution without verification notes, potentially inflating perceptions of U.S. decline or FDA progress.
Omitted Verifiable Facts
The article's positive framing skips concrete developments that contextualize Makary's "successes":
- White House replacement plan: Officials signed off on ousting Makary amid drug approval delays (Washington Post, May 2026).
- Internal FDA reports: Documented "paranoia, turmoil, and backlash" over slow approvals for cancer and Huntington’s treatments, per patient groups (Seattle Times, May 2026).
These omissions matter as they directly tie to the bipartisan criticisms mentioned but unexplored, altering reader understanding of agency stability.
Author and Outlet Context
- Megan Brock: Investigative reporter at conservative Daily Caller (30+ bylines on medical controversies like transgender care); contributes to Daily Wire. Her nurse background informs health reporting, but focus aligns with outlet priorities (e.g., criticizing Planned Parenthood).
- Daily Wire: Rated right-leaning by AllSides/Media Bias Fact Check; appeals to conservative audiences via founder Ben Shapiro.
No retractions or major errors noted in her record.
Coverage Comparison
- Daily Wire emphasizes Makary's defenses and initiatives.
- Contrasting angles:
| Outlet | Focus | Key Difference |
|---|---|---|
| Washington Post | White House plan to replace Makary over delays/vaccines | Anonymous sourcing on dysfunction; ignores Makary's quotes. |
| Seattle Times | Internal "paranoia and backlash" on approvals | Staff accounts of chaos; no mention of dyes or mifepristone study. |
Bottom Line
Strong on exclusive reporting and verified pilots, this piece informs on Makary's perspective without fabrication—but unverified claims and omitted turmoil reports tilt toward favorable framing. Readers gain Makary's side; cross-referencing left-leaning outlets yields fuller agency picture. Solid journalism with partisan lean, not deception.
Further Reading
- Washington Post: White House plan to replace FDA Commissioner Makary
- Seattle Times: Paranoia, turmoil, and backlash inside the FDA under Marty Makary
- CNBC: FDA under Makary coverage
*(Word count: 612)*
Investigation Log · 48 steps
Starting investigation...
Investigating Daily Wire
Investigating Megan Brock
Investigating Martin Makary
Searching for ""FDA trust in science historic lows" 2025 OR 2026"
Verify claim about Americans’ trust in science and medicine at historic lows
Searching for ""China phase one trials" "four times" US FDA Makary"
Verify Makary's claim about China doing 4x phase one trials as US before his tenure
Source: Daily Wire
The Daily Wire is an American media company headquartered in Nashville, Tennessee, with 115 full-time employees, producing news, opinion, podcasts, films, and video content, often repackaging journalism from traditional sources with a conservative slant. No specific fact-checking scores or scientific studies on accuracy are provided in the sources. A YouTube video claims multiple unnamed scientific studies label it a fake news site.
Source: Martin Makary
Martin Makary is a British-American surgeon, professor at Johns Hopkins School of Medicine (Mark Ravitch Chair in Gastrointestinal Surgery, chief of Islet Transplant Surgery), and author of books like *The Price We Pay* (2019) and *Blind Spots* (2024), with over 250 peer-reviewed publications and WHO contributions. Confirmed as the 27th FDA Commissioner on March 25, 2025, by bipartisan U.S. Senate vote under President Trump. Endorsed by figures like Don Berwick, Senator William Frist, Cass Sunstein, and Eric Topol.
Source: Megan Brock
Megan Brock is listed as an investigative reporter for The Daily Caller, with over 30 bylined articles, many marked 'EXCLUSIVE' on topics like transgender inmates in prisons and gender treatments for minors. She has a professional background as a former critical care registered nurse with an active Pennsylvania license, alongside roles as a small business owner and documentary photographer. No fact-checking records, awards, or retractions are mentioned; her work appears in conservative outlets like Daily Caller and Daily Wire, raising questions about selective focus on medical controversies aligning with those sites' priorities.
Searching for ""FDA" "phase out" OR "remove" "artificial dyes" OR "petroleum-based food dyes" Makary OR Trump 2025 OR 2026"
Verify claim about FDA announcing phase out of nine artificial dyes
Searching for ""FDA" "mifepristone" "granular study" OR "detailed study" Makary"
Verify Makary's claim on mifepristone safety study underway
Searching for ""FDA school lunch pilot" pesticides OR "heavy metals" reduction Makary"
Verify school lunch pilot program results: 70-80% pesticides reduction, 80-90% heavy metals
Searching for ""FDA infant formula" testing "300 samples" OR "largest-ever testing" April 2025 OR 2026 Makary PFAS"
Verify infant formula testing results released April 29
Searching for ""Biden administration" overruled scientists "COVID vaccine" "healthy children""
Verify Makary's claim that Biden overruled scientists on kid COVID vax
Searching for ""FDA Commissioner’s National Priority Voucher program" OR "priority voucher" rare diseases Makary"
Verify new voucher program and review times down to 1-2 months
Comparing coverage of "FDA Commissioner Martin Makary interview Daily Wire science politics"
Coverage comparison completed
Source Credibility
Article published by right-wing outlet Daily Wire, whose founder Ben Shapiro and content appeals to conservative audiences, conducting an exclusive interview with Trump-appointed FDA Commissioner Makary and presenting his claims favorably without pushback.
Readers may not recognize the outlet's conservative bias, leading them to view Makary's self-reported achievements as neutral journalism rather than aligned advocacy.
unverified_claim
"When I came into office 14 months ago, the year prior, China was doing four times the number of phase one trials as the United States" – Makary's quote presented without verification.
Undermines credibility of Makary's narrative on U.S. scientific leadership decline under Biden if unconfirmed, potentially exaggerating the "mess" inherited.
unverified_claim
"There needs to be a good, detailed granular study for mifepristone... We have committed to conducting a granular study" – Makary's claim on underway study, reported without external confirmation.
Presents FDA action on controversial abortion drug as in progress without evidence, potentially reassuring pro-life readers while unverified.
unverified_claim
"The Biden administration overruled scientists who recommended against approving the Covid vaccine for healthy children. It was a fiasco." – Makary's assertion reported as is.
Attributes policy failure to Biden without evidence, reinforcing partisan contrast favoring Trump FDA.
Framing
Leads with and heavily features Makary's positive self-assessment ("gold standard science," successes vs. Big Food/Pharma) while briefly noting criticisms from both sides without detail or counter-quotes.
Creates impression of effective, apolitical leadership under Trump despite bipartisan flak and internal issues reported elsewhere.
Missing Context
FDA under Makary faces internal turmoil, paranoia, backlash, and White House considerations to replace him due to slow drug approvals and vaccine policy criticisms.
Provides critical context to Makary's "success" narrative and bipartisan criticisms mentioned but not detailed, balancing the exclusive puff-piece tone.
Searching for ""FDA" "nine artificial dyes" OR "all nine artificial dyes" phase out OR remove Makary"
Follow-up: Article specifies "all nine artificial dyes"; verify exact claim
Searching for "FDA "decision letters" public OR "complete response letters" public Makary transparency"
Verify new transparency policy on drug rejection letters
unverified_claim
"We announced action to remove all nine artificial dyes from the U.S. food supply" – Makary's specific claim on nine petroleum-based dyes, presented without verification.
Inflates perception of decisive FDA action if the "nine" or full phase-out isn't confirmed, as FDA site only lists general "Removing artificial food dyes."
Cherry-Picking
Highlights school lunch pilot success (70-80% pesticide reduction) and infant formula testing as "resounding success," while briefly noting but dismissing drug rejection criticisms.
Emphasizes wins to build "gold standard science" narrative, downplaying patient groups' complaints on slow rare disease approvals.
Missing Context
FDA under Makary has approved some drugs quickly via new voucher but faces accusations of slow-walking others, including cancer and Huntington’s treatments, per patient groups and reporting.
Balances Makary's "if it works, approved" claim and defenses against criticisms mentioned but not explored.
Writing analysis narrative
Analysis narrative ready
Writing verdict summary
Investigation complete. Preparing report...
The Compass
You see how this outlet sees the world.
How do you see it? Find your political shape in a few minutes.
Take the testOr check your own article